Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Tony Seidl lead

Europe

Tony’s two-wheel tour: a man, a bike and a Parkinson’s promise

Daily diary entries during epic 11-day bike tour across the Alps

READ MORE
Barbara Morandi does outdoor yoga.

Special reports

3 complementary therapies for Parkinson’s disease and sleep

We find out more about therapies including shiatsu and Ayurveda treatments

READ MORE

In my country

Parkinson’s in South Africa

An in-depth look at how Parkinson's is managed in South Africa

READ MORE